Table 1. Relationships between the expression of LINC00152 and clinicalpathological characteristics in 97 patients with GC.
| Characteristics | Expression of LINC00152 | P value | |
|---|---|---|---|
| Low (n = 48) | High (n = 49) | ||
| Gender | 0.823 | ||
| Male | 35 | 34 | |
| Female | 13 | 15 | |
| Age | 0.219 | ||
| ≤60 | 25 | 32 | |
| >60 | 23 | 17 | |
| Histological grade | 0.418 | ||
| Well/moderate | 20 | 25 | |
| other | 28 | 24 | |
| Tumor invasion depth (T) | 0.029 | ||
| Tis, T1, T2 | 20 | 10 | |
| T3 or above | 28 | 39 | |
| Lymph node metastasis (N) | 0.047 | ||
| N0 | 14 | 6 | |
| N1 or above | 34 | 43 | |
| TNM stage | 0.025 | ||
| I/II | 32 | 21 | |
| III/IV | 16 | 28 | |
| Tumor location | 0.712 | ||
| Antrum | 17 | 17 | |
| Cardia | 15 | 11 | |
| Angulus | 12 | 13 | |
| Body | 2 | 5 | |
| Full stomach | 2 | 3 | |
| Laure's classification | 0.993 | ||
| Intestinal | 20 | 21 | |
| Diffuse | 24 | 24 | |
| Mixed | 4 | 4 | |